Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
1.150
0.00 (0.00%)
At close: Dec 20, 2024, 2:54 PM
1.210
+0.060 (5.22%)
After-hours: Dec 20, 2024, 7:44 PM EST
Theriva Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -26.69 | -18.35 | -19.69 | -14.27 | -10.04 | -15.3 | |
| Depreciation & Amortization | 0.15 | 0.14 | 0.09 | 0.09 | 0.2 | 0.24 | |
| Asset Writedown & Restructuring Costs | 6.92 | - | - | - | - | - | |
| Stock-Based Compensation | 0.65 | 0.55 | 0.48 | 0.42 | 0.35 | 0.34 | |
| Other Operating Activities | -1.53 | -3.64 | 0.85 | 0.17 | 0.11 | -0.01 | |
| Change in Accounts Payable | -0.1 | -0.16 | -0.39 | -0.36 | -1.43 | 1.28 | |
| Change in Other Net Operating Assets | 1.82 | 2.47 | -0.42 | 1.07 | -1.35 | -0.43 | |
| Operating Cash Flow | -18.79 | -19 | -19.08 | -12.89 | -12.17 | -13.87 | |
| Capital Expenditures | -0.06 | -0.2 | -0.12 | -0.01 | -0.01 | - | |
| Cash Acquisitions | - | - | -3.86 | - | - | - | |
| Investing Cash Flow | -0.06 | -0.2 | -4.4 | -0.01 | -0.01 | - | |
| Long-Term Debt Repaid | - | -0.08 | -1.38 | - | - | - | |
| Net Debt Issued (Repaid) | -0.07 | -0.08 | -1.38 | - | - | - | |
| Issuance of Common Stock | 5.62 | 2.22 | - | 74 | 3.36 | - | |
| Repurchase of Common Stock | - | - | -0.29 | - | - | - | |
| Other Financing Activities | -1.52 | -1.52 | -3 | - | - | - | |
| Financing Cash Flow | 4.03 | 0.63 | -1.93 | 74 | 3.36 | - | |
| Foreign Exchange Rate Adjustments | 0.07 | -0.03 | -0.03 | - | - | - | |
| Net Cash Flow | -14.75 | -18.61 | -25.44 | 61.1 | -8.82 | -13.87 | |
| Free Cash Flow | -18.84 | -19.2 | -19.2 | -12.9 | -12.18 | -13.87 | |
| Free Cash Flow Per Share | -22.96 | -29.80 | -31.31 | -26.47 | -160.13 | -210.99 | |
| Levered Free Cash Flow | -12.89 | -14.4 | -10.42 | -7.51 | -8.3 | -8.25 | |
| Unlevered Free Cash Flow | -12.89 | -14.4 | -10.42 | -7.51 | -8.3 | -8.25 | |
| Change in Net Working Capital | 1.02 | 1.09 | -1.16 | -0.93 | 2.67 | -0.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.